Prognos Health’s Post

🔍 Discover the key benefits of our 2024 IDN Oncology Trend Report: ➡ Growing Oncology Reach: Learn how IDNs are increasing patient volumes and enhancing their dispensing power. ➡ Sophisticated Drug Management: Understand the impact of advanced tools like formularies and high-cost drug reviews on patient access. ➡ Effective Engagement: Get tailored strategies from our new playbook to connect with oncologists and pharmacists. Unlock these insights and more to drive success in your oncology strategies! 🔗 https://lnkd.in/en5F4pFU #Oncology #Healthcare #DrugManagement #PharmaInsights #MarketResearch

🎥 Dive into the future of diagnostics with our recent STAT webinar: "Is this the era of AI diagnostics?" Dr. Gazala Khan, Medical Oncologist Specialist at Henry Ford Hospital, shares her insights on how AI diagnostics and pathology are expediting oncology care. Hear from leading pharmaceutical, clinical, and AI experts as they discuss how AI diagnostics are transforming the healthcare industry: https://lnkd.in/eY_BW5qp

New medications, #Jemperli and #Korsuva will be available for #endometrialcancer and chronic #kidney disease https://lnkd.in/gfn_muVG #pharma #pharmaceutical #Science #TeleMedicine #news #media #patientcare #healthcare #MedComms #MedicalAffairs #Medical #PatientSafety #cancer #cancerresearch

Making well-informed decisions is crucial when every pharmaceutical company is chasing opportunities that will address high unmet medical needs, obtain commercial success, and speed to market. Explore how our experts are leveraging AssetNav, part of InizioNavigator, to help clients navigate the complexities of oncology and beyond, delivering actionable insights that drive confident decision-making. Read the full blog by John L'Ecuyer, Executive Director at Putnam: https://lnkd.in/entdftEy #Pharma #AI #AssetNav #Oncology #DataDriven #HealthcareInnovation

For #Patients AND #Providers: “I thought I knew what it was like putting myself in the patient’s shoes before I was diagnosed with cancer. But no…as a patient, it’s very different.” Read one healthcare industry expert’s personal story and gain insights into enhancing the patient-provider partnership journey.  Learn more: https://lnkd.in/eq7KupBF Rocio Manghani David Dierk Kendig Bergstresser #patientjourney #tripleaim #quintupleaim #QCHealth #pharmaceutical #marketaccess #aventria

Do you have questions about the 505(b)(2) drug approval pathway? Learn about the challenges and opportunities of this approval process as Tyler Wood, system director of pharmacy oncology & biosimilars, speaks with Carolyn Liptak of Vizient, Inc. Listen here: http://ms.spr.ly/6045c9K6F #pharmacy #healthcareleaders

Five Quick Facts to Know About Biosimilars: The biosimilar space continues to grow, with key focuses around retina and oncology, but adoption remains slow in the United States. #finance #pharmacy #lifesciences

Research reveals that ~64% of potentially eligible patients are not benefiting from precision oncology therapies. As a solutions provider committed to improving the landscape of personalized medicine, we recognize the urgency of addressing clinical practice gaps. Our newest article details the challenges pharmaceutical companies commonly face when integrating predictive biomarker testing into clinical care. Read the article here: https://lnkd.in/e3Vc2zUF

Thoughts on this? >> J&J’s multiple myeloma therapies drive oncology business despite slow Carvykti sales >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #productmarketing #biotech #pharma

Thanks to World Pharmaceutical Frontiers and Clinical Trials Insight for the conversation and article around the evolving dynamics of clinical trials and associated costs. There are many aspects to consider on this topic such as accelerating clinical trials, supply chain partnerships, technological advancements and the utilization of data and AI. Here is the link to the article: https://lnkd.in/ezQ8-scm #pharma #clinicaltrials #biopharma #clinicalresearch #medicine #EY #EYConsulting #EYClinicalTrialFastLane #cancer #research #cancertrials #cancercenters #medicalresearch #accelerationpatientimpact #accelerateclinicaltrials #medtech #meddevice